Home

üreg Kiegészítés becsületes anti sdha antibody kappa opioid Év Konjugált összetett

SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)
SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)

Recombinant Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) | Abcam
Recombinant Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) | Abcam

Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink

Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink

Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination | Journal of Neuroscience
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination | Journal of Neuroscience

Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System

SDHA Antibody | Cell Signaling Technology
SDHA Antibody | Cell Signaling Technology

Anti-Kappa Opioid Receptor antibody - N-terminal (ab194371) | Abcam
Anti-Kappa Opioid Receptor antibody - N-terminal (ab194371) | Abcam

RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text

Primary Antibodies for Diverse Immunoassays: i.a. IHC - dianova
Primary Antibodies for Diverse Immunoassays: i.a. IHC - dianova

SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)
SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)

Anti-SDHA Antibody (A14093) | Antibodies.com
Anti-SDHA Antibody (A14093) | Antibodies.com

Primary Antibodies: Phospho-Antibodies - Page 420 of 420 - dianova Int.
Primary Antibodies: Phospho-Antibodies - Page 420 of 420 - dianova Int.

Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience

Kappa opioid receptor agonists improve postoperative cognitive dysfunction in rats via the JAK2/STAT3 signaling pathway
Kappa opioid receptor agonists improve postoperative cognitive dysfunction in rats via the JAK2/STAT3 signaling pathway

Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine - ScienceDirect
Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine - ScienceDirect

Recombinant Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) | Abcam
Recombinant Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) | Abcam

Anti-Kappa Opioid Receptor Antibody (A89716) | Antibodies.com
Anti-Kappa Opioid Receptor Antibody (A89716) | Antibodies.com

SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)
SDHA Monoclonal Antibody (2E3GC12FB2AE2) (459200)

Cardiolipin and OPA1 Team up for Methamphetamine-Induced Locomotor Activity by Promoting Neuronal Mitochondrial Fusion in the Nucleus Accumbens of Mice | ACS Chemical Neuroscience
Cardiolipin and OPA1 Team up for Methamphetamine-Induced Locomotor Activity by Promoting Neuronal Mitochondrial Fusion in the Nucleus Accumbens of Mice | ACS Chemical Neuroscience

Anti-Kappa Opioid Receptor Antibody (A16150) | Antibodies.com
Anti-Kappa Opioid Receptor Antibody (A16150) | Antibodies.com

SDHA antibody (66588-1-Ig) | Proteintech
SDHA antibody (66588-1-Ig) | Proteintech

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports